If you're wondering whether your employer can require you to get a COVID-19 vaccine to return to work, the short answer is yes.https://t.co/X1hnMLwBfz

— FOX 11 Los Angeles (@FOXLA) December 4, 2020

“Pfizer wouldn’t say where shortfalls over ingredients arose as it ramped up production. Vaccines typically contain materials from suppliers that can include antivirus agents, antiseptic liquids, sterile water and elements of the DNA of the virus itself” https://t.co/tPgOWigX8u

— Barbara Malmet (@B52Malmet) December 4, 2020

BREAKING— Pfizer is slashing its expected delivery of vaccine doses from 100 million to 50 million because of production quality issues. Everyone needs 2 doses. So this is a big hit. #COVID19 https://t.co/VfJXorRAWA

— Eric Feigl-Ding (@DrEricDing) December 3, 2020

oh oh

Pfizer Slashed Its Original Covid-19 Vaccine Rollout Target After Supply-Chain Obstacles - WSJ https://t.co/ufJYnZQ4WL

— Suze Michelini (@emilia_suze) December 4, 2020

Better headline: Excellent QC prevents disastrous vaccine mishap.https://t.co/4eZhWe3U8u

— Casey Simons (@nmr_chemist) December 4, 2020

Our ⁦@biological_e⁩ collaborators are scaling up to produce 1.2 billion doses of our ⁦@TexasChildrens⁩ low cost recombinant protein RBD refrigerated #COVID19 now in clinical testing across India. Hoping we can get financing for the US as well.. https://t.co/9xyieYNLwp

— Prof Peter Hotez MD PhD (@PeterHotez) December 4, 2020

Spaffer will be lucky if he survives as PM to the end of February...

This is just a diversion from the awful #COVID fatality figures and the fact that Pfizer is going to be much slower at supplying vaccine than BJ promised...https://t.co/dqJruX2vq6

— Proof in the Putting (@HereBeProof) December 4, 2020

Interesting WSJ piece claiming supply chain issues will mean less of the biontech/Pfizer vaccine this year - says expectation for UK of 4-5m in 2020 rather than 10m talked about ... https://t.co/85iDrWueFx

— Faisal Islam (@faisalislam) December 3, 2020

(WSJ) - Pfizer Inc. expects to ship half of the Covid-19 vaccines it originally planned for this year because of supply-chain problems, but still expects to roll out more than a billion doses in 2021.

⁦@WSJ⁩ $PFE https://t.co/7PqEs44fEe

— Carl Quintanilla (@carlquintanilla) December 3, 2020

Suspect we'll see more news like this-- manufacturing at this pace is not trivial: https://t.co/9maERN9mzh

— Lisa Jarvis (@lisamjarvis) December 3, 2020

WSJ: Pfizer expects to ship half of the COVID vaccines it originally planned for this year because of supply-chain problems (50m down from 100m) https://t.co/jgXsyYKQZ2

— Brandon Wall (@Walldo) December 3, 2020

What happens when there’s not enough for the second dose? https://t.co/p3p1qoCKo7

— Susan (@redwitch497) December 4, 2020

Pfizer cut 2020 coronavirus vaccine target in half after supply-chain hurdles https://t.co/SbE7xzH4Lm

— Lydia Moynihan (@LJMoynihan) December 3, 2020

Pharma giant expects to ship half the doses it had originally planned after finding raw materials in early production didn’t meet its standards. https://t.co/HWrVMrx0EX

— Linda Hill (@bulldoghill) December 4, 2020

Pfizer Slashed Its Original Covid-19 Vaccine Rollout Target After Supply-Chain Obstacles

Pharma giant expects to ship half the doses it had originally planned after finding raw materials in early production didn’t meet its standardshttps://t.co/jYbLDV4a8h

— Amit Paranjape (@aparanjape) December 4, 2020